肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

八色流式细胞术监测白血病相关免疫表型在成人b急性淋巴细胞白血病中的预后意义

Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia

原文发布日期:2013-08-16

DOI: 10.1038/bcj.2013.31

类型: Original Article

开放获取: 是

英文摘要:

摘要翻译: 

原文链接:

文章:

八色流式细胞术监测白血病相关免疫表型在成人b急性淋巴细胞白血病中的预后意义

Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia

原文发布日期:2013-08-16

DOI: 10.1038/bcj.2013.31

类型: Original Article

开放获取: 是

 

英文摘要:

Minimal residual disease (MRD) is of the most important factor for predicting prognosis and guiding treatment of acute lymphoblastic leukemia (ALL). In this study, we investigated the prognostic significance of leukemia-associated immunophenotypes (LAIPs) as assessment of index of MRD in 125 adult B-lineage ALL (B-ALL) patients by eight-color flow cytometry. The LAIPs could be identified in 96% and 81.6% of patients with the sensitivity of 10−4 and 10−5, respectively. MRD-negative status could clearly predict a favorable 2-year relapse-free survival (RFS) and overall survival (OS) at the end of induction of complete remission and one cycle of consolidation treatment. Moreover, we identified a group of cases with MRD of 0.001% to <0.01%, which showed significantly higher 2-year relapse rate than those with undetectable one. In multivariate analysis, MRD status was associated with RFS or OS independently. Furthermore, MRD assessed by LAIPs and RQ-PCR assay for patients with BCR-ABL fusion gene yielded concordant results in 89.7% of cases. In conclusion, MRD evaluated by eight-color flow cytometry could provide an important tool to assess treatment response and prognosis precisely in adult B-ALL.

 

摘要翻译: 

微小残留病(MRD)是预测急性淋巴细胞白血病(ALL)预后和指导治疗的最重要因素。本研究通过八色流式细胞术检测125例成人B系急性淋巴细胞白血病(B-ALL)患者白血病相关免疫表型(LAIPs),以评估MRD指标的预后意义。在检测灵敏度为10^-4和10^-5时,分别有96%和81.6%的患者可识别出LAIPs。达到完全缓解诱导治疗结束及一个周期巩固治疗后的MRD阴性状态,可明确预测良好的2年无复发生存期(RFS)和总生存期(OS)。此外,我们发现MRD水平在0.001%至<0.01%的病例组,其2年复发率显著高于MRD不可测组。多变量分析显示,MRD状态与RFS或OS独立相关。进一步对携带BCR-ABL融合基因的患者采用LAIPs与实时定量PCR(RQ-PCR)检测MRD,结果显示89.7%的病例检测结果一致。综上所述,通过八色流式细胞术评估MRD可为精准判断成人B-ALL治疗反应及预后提供重要工具。

 

原文链接:

Prognostic significance of monitoring leukemia-associated immunophenotypes by eight-color flow cytometry in adult B-acute lymphoblastic leukemia

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……